Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Hypersensitivity | 4 | 2023 | 96 | 1.480 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2025 | 13 | 0.970 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2025 | 14 | 0.970 |
Why?
|
| Hypersensitivity | 2 | 2023 | 182 | 0.700 |
Why?
|
| Respiratory Tract Infections | 2 | 2023 | 263 | 0.640 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 2396 | 0.630 |
Why?
|
| Leiomyoma | 1 | 2017 | 90 | 0.540 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 118 | 0.530 |
Why?
|
| Outpatients | 3 | 2023 | 254 | 0.500 |
Why?
|
| Progesterone | 1 | 2017 | 624 | 0.470 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 550 | 0.450 |
Why?
|
| Ascaridoidea | 1 | 2022 | 6 | 0.410 |
Why?
|
| Ascaridida Infections | 1 | 2022 | 6 | 0.410 |
Why?
|
| Mycobacterium bovis | 1 | 2022 | 35 | 0.390 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2022 | 26 | 0.390 |
Why?
|
| Meningitis | 1 | 2022 | 99 | 0.390 |
Why?
|
| Myelitis | 1 | 2022 | 15 | 0.390 |
Why?
|
| Cronobacter sakazakii | 1 | 2021 | 5 | 0.390 |
Why?
|
| Myositis | 1 | 2022 | 51 | 0.380 |
Why?
|
| Enterovirus | 1 | 2022 | 48 | 0.380 |
Why?
|
| Penicillins | 4 | 2023 | 154 | 0.380 |
Why?
|
| Enterovirus Infections | 1 | 2022 | 42 | 0.380 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2021 | 55 | 0.370 |
Why?
|
| Antimicrobial Stewardship | 1 | 2022 | 84 | 0.360 |
Why?
|
| Infant Formula | 1 | 2021 | 98 | 0.360 |
Why?
|
| Meningitis, Bacterial | 1 | 2021 | 93 | 0.360 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2020 | 20 | 0.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1866 | 0.340 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 244 | 0.340 |
Why?
|
| Child | 13 | 2025 | 24219 | 0.340 |
Why?
|
| Milk, Human | 1 | 2022 | 300 | 0.330 |
Why?
|
| Exanthema | 1 | 2020 | 68 | 0.330 |
Why?
|
| Public Health | 1 | 2021 | 261 | 0.320 |
Why?
|
| Fever | 1 | 2020 | 296 | 0.290 |
Why?
|
| Abscess | 1 | 2019 | 138 | 0.290 |
Why?
|
| Pneumonia | 1 | 2020 | 325 | 0.270 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 629 | 0.270 |
Why?
|
| Osteomyelitis | 1 | 2019 | 204 | 0.260 |
Why?
|
| Tuberculosis | 1 | 2022 | 573 | 0.250 |
Why?
|
| Electronic Health Records | 1 | 2022 | 699 | 0.250 |
Why?
|
| Sialic Acids | 1 | 2014 | 19 | 0.240 |
Why?
|
| Disease Management | 1 | 2019 | 515 | 0.240 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 57 | 0.240 |
Why?
|
| Influenza A Virus, H7N9 Subtype | 1 | 2014 | 29 | 0.230 |
Why?
|
| Texas | 3 | 2025 | 3546 | 0.230 |
Why?
|
| Infant | 5 | 2025 | 12334 | 0.210 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 469 | 0.200 |
Why?
|
| Primary Health Care | 3 | 2023 | 752 | 0.190 |
Why?
|
| Humans | 16 | 2025 | 123122 | 0.190 |
Why?
|
| Pediatrics | 1 | 2020 | 1139 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 1 | 2025 | 1584 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2025 | 16003 | 0.180 |
Why?
|
| Child, Preschool | 4 | 2025 | 13874 | 0.170 |
Why?
|
| Brain | 1 | 2021 | 2945 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2014 | 744 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2014 | 1019 | 0.160 |
Why?
|
| Female | 8 | 2025 | 65443 | 0.150 |
Why?
|
| Role | 1 | 2017 | 26 | 0.150 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 229 | 0.140 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 160 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 509 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2017 | 1101 | 0.120 |
Why?
|
| Male | 6 | 2025 | 60036 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1336 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1682 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2023 | 4704 | 0.110 |
Why?
|
| Philadelphia | 1 | 2022 | 25 | 0.100 |
Why?
|
| I-kappa B Kinase | 1 | 2022 | 60 | 0.100 |
Why?
|
| Streptococcus agalactiae | 1 | 2022 | 105 | 0.100 |
Why?
|
| BCG Vaccine | 1 | 2022 | 115 | 0.090 |
Why?
|
| Disease Progression | 1 | 2017 | 2023 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2017 | 2813 | 0.090 |
Why?
|
| Skin Tests | 1 | 2021 | 75 | 0.090 |
Why?
|
| Inappropriate Prescribing | 1 | 2020 | 41 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1677 | 0.090 |
Why?
|
| Myalgia | 1 | 2020 | 11 | 0.090 |
Why?
|
| Disease Vectors | 1 | 2020 | 24 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2306 | 0.090 |
Why?
|
| Cephalosporins | 1 | 2020 | 138 | 0.090 |
Why?
|
| Feedback | 1 | 2020 | 162 | 0.080 |
Why?
|
| Doxycycline | 1 | 2020 | 117 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 320 | 0.080 |
Why?
|
| Hospitals | 1 | 2022 | 397 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2022 | 8101 | 0.080 |
Why?
|
| Vaccination | 1 | 2022 | 949 | 0.070 |
Why?
|
| Adolescent | 1 | 2025 | 19091 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3249 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2021 | 623 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 710 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1873 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12121 | 0.060 |
Why?
|
| Chemokines | 1 | 2014 | 137 | 0.060 |
Why?
|
| Animals | 3 | 2022 | 33708 | 0.060 |
Why?
|
| Hospitalization | 1 | 2021 | 1734 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 1001 | 0.050 |
Why?
|
| Virus Replication | 1 | 2014 | 603 | 0.050 |
Why?
|
| Cytokines | 1 | 2014 | 1281 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 5771 | 0.040 |
Why?
|
| Lung | 1 | 2014 | 1474 | 0.030 |
Why?
|
| Mice | 1 | 2014 | 17483 | 0.020 |
Why?
|